Source: Annual Congress 2007 - Primary care respiratory problems
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Wang, B. Mao, T. Q. Li, Z. L. Wang (Chengdu, China). Serum leptin level may be a predictor of bone mineral loss in patients with chronic obstructive pulmonary disease. Eur Respir J 2007; 30: Suppl. 51, 4058

Member's Comments

No comment yet.

Related content which might interest you: The effects of serum leptin on bone metabolism in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Loss of bone mineral density in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Primary care management of COPD Year: 2007 Plasma inflammatory markers associated with bone resorption in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008 Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 Serum magnesium levels of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Bone mineral density changes in male patients with chronic obstructive pulmonary disease: clinical and biochemical variables in correlation with glucocorticoids use Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Plasma orexin-A level and body composition in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 485s Year: 2001 Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Study of bone mineral density, hemogram and their correlations in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Biomarkers to predict decreased bone mineral density in patients with chronic respiratory failure Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Clinical severity of chronic obstructive pulmonary disease is associated with bone mineral density Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015 Association between serum leptin, nutritional status and severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008 Serum amyloid A in patients with stable chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Serum levels of undercarboxylated osteocalcin as a biomarker to predict bone mineral density in patients with chronic respiratory diseases Source: Annual Congress 2010 - Rehabilitation: more than just exercise Year: 2010 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015